Adiponectin and Polycystic Ovary Syndrome
- 24 May 2010
- journal article
- research article
- Published by SAGE Publications in Biological Research For Nursing
- Vol. 12 (1) , 62-72
Abstract
Introduction. Polycystic ovary syndrome (PCOS) has a prevalence of 5—8% in women of reproductive age. Women with PCOS have an increased risk of metabolic syndrome and associated comorbidities. Adiponectin is a circulating protein produced by adipocytes. Circulating levels of adiponectin are inversely related to adipocyte mass. Low levels occur with insulin resistance, type 2 diabetes, metabolic syndrome, and obesity-related cardiovascular disease. This article reviews the literature on the link between adiponectin and PCOS and the potential use of adiponectin as a biomarker for PCOS. Method. Data-based studies on adiponectin and PCOS and adiponectin measurement were identified through the Medline (1950—2009) and ISI Web of Knowledge (1973—2009) databases. Results. Fifteen studies related to adiponectin and PCOS met inclusion criteria and were included in this review. These studies present evidence that adiponectin is linked to insulin resistance, insulin sensitivity, body mass index (BMI), and adiposity. In women with PCOS, lower levels, as opposed to higher levels, of adiponectin occur in the absence of adiposity. Conclusion. The relationships between adiponectin and insulin resistance and sensitivity, metabolic syndrome, and BMI in women with PCOS suggest that adiponectin potentially could serve as a marker for disease risk and provide opportunity for earlier intervention if knowledge is successfully translated from laboratory to clinical practice. However, further study of the relationship between adiponectin and PCOS is required before there can be direct application to clinical practice.Keywords
This publication has 51 references indexed in Scilit:
- Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS StudObesity, 2009
- Comparison of Immunoassays for the Selective Measurement of Human High–Molecular Weight AdiponectinClinical Chemistry, 2009
- Adipokines and the clinical laboratory: what to measure, when and how?Journal of Clinical Pathology, 2009
- Plasma Adiponectin Concentrations Are Associated with Body Composition and Plant-Based Dietary Factors in Female TwinsThe Journal of Nutrition, 2009
- Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fatInternational Journal of Gynecology & Obstetrics, 2008
- Adipocytokines and the Metabolic Complications of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Effect of obesity and insulin sensitivity on adiponectin isoform distributionEuropean Journal of Clinical Investigation, 2008
- Calcium Is Involved in Formation of High Molecular Weight AdiponectinMetabolic Syndrome and Related Disorders, 2008
- Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndromeFertility and Sterility, 2008
- Hepatocyte Nuclear Factor-4α P2 Promoter Haplotypes Are Associated With Type 2 Diabetes in the Japanese PopulationDiabetes, 2006